Literature DB >> 26633600

A full competing risk analysis of hospital-acquired infections can easily be performed by a case-cohort approach.

Martin Wolkewitz1, Mercedes Palomar-Martinez2, Pedro Olaechea-Astigarraga3, Francisco Alvarez-Lerma4, Martin Schumacher5.   

Abstract

OBJECTIVES: We provide a case-cohort approach and show that a full competing risk analysis is feasible even in a reduced data set. Competing events for hospital-acquired infections are death or discharge from the hospital because they preclude the observation of such infections. STUDY DESIGN AND
SETTING: Using surveillance data of 6,568 patient admissions (full cohort) from two Spanish intensive care units, we propose a case-cohort approach which uses only data from a random sample of the full cohort and all infected patients (the cases). We combine established methodology to study following measures: event-specific as well as subdistribution hazard ratios for all three events (infection, death, and discharge), cumulative hazards as well as incidence functions by risk factor, and also for all three events.
RESULTS: Compared with the values from the full cohort, all measures are well approximated with the case-cohort design. For the event of interest (infection), event-specific and subdistribution hazards can be estimated with the full efficiency of the case-cohort design. So, standard errors are only slightly increased, whereas the precision of estimated hazards of the competing events is inflated according to the size of the subcohort.
CONCLUSION: The case-cohort design provides an appropriate sampling design for studying hospital-acquired infections in a reduced data set. Potential effects of risk factors on the competing events (death and discharge) can be evaluated.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Competing risk model; Cox proportional hazards model; Cumulative incidence function; Fine and Gray model; Multistate model; Nosocomial infections; Sampling designs; Subdistribution

Mesh:

Year:  2015        PMID: 26633600     DOI: 10.1016/j.jclinepi.2015.11.011

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  8 in total

1.  Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.

Authors:  Edward K Duran; Aaron W Aday; Nancy R Cook; Julie E Buring; Paul M Ridker; Aruna D Pradhan
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

2.  Nonparametric Assessment of Differences Between Competing Risk Hazard Ratios: Application to Racial Differences in Pediatric Chronic Kidney Disease Progression.

Authors:  Derek K Ng; Daniel A Antiporta; Matthew B Matheson; Alvaro Muñoz
Journal:  Clin Epidemiol       Date:  2020-01-20       Impact factor: 4.790

3.  Competing risks regression models with covariates-adjusted censoring weight under the generalized case-cohort design.

Authors:  Yayun Xu; Soyoung Kim; Mei-Jie Zhang; David Couper; Kwang Woo Ahn
Journal:  Lifetime Data Anal       Date:  2022-01-15       Impact factor: 1.588

4.  Inverse Probability Weighting Enhances Absolute Risk Estimation in Three Common Study Designs of Nosocomial Infections.

Authors:  Maja von Cube; Derek Hazard; James Balmford; Paulina Staus; Sam Doerken; Ksenia Ershova; Martin Wolkewitz
Journal:  Clin Epidemiol       Date:  2022-09-14       Impact factor: 5.814

5.  Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis.

Authors:  Ryunosuke Saiki; Yukihide Momozawa; Yasuhito Nannya; Masahiro M Nakagawa; Yotaro Ochi; Tetsuichi Yoshizato; Chikashi Terao; Yutaka Kuroda; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Atsushi Niida; Seiya Imoto; Koichi Matsuda; Takayuki Morisaki; Yoshinori Murakami; Yoichiro Kamatani; Shuichi Matsuda; Michiaki Kubo; Satoru Miyano; Hideki Makishima; Seishi Ogawa
Journal:  Nat Med       Date:  2021-07-08       Impact factor: 53.440

6.  EFFECT of daily antiseptic body wash with octenidine on nosocomial primary bacteraemia and nosocomial multidrug-resistant organisms in intensive care units: design of a multicentre, cluster-randomised, double-blind, cross-over study.

Authors:  Anne Meißner; Dirk Hasenclever; Oana Brosteanu; Iris Freya Chaberny
Journal:  BMJ Open       Date:  2017-11-08       Impact factor: 2.692

7.  The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis.

Authors:  Wen Xiu Chang; Ning Xu; Takanori Kumagai; Takeshi Shiraishi; Takahiro Kikuyama; Hiroki Omizo; Kazuhiro Sakai; Shigeyuki Arai; Yoshifuru Tamura; Tatsuru Ota; Shigeru Shibata; Yoshihide Fujigaki; Zhong Yang Shen; Shunya Uchida
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

8.  Burden of Antimicrobial Resistance: Compared to What?

Authors:  Marlieke E A de Kraker; Marc Lipsitch
Journal:  Epidemiol Rev       Date:  2022-01-14       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.